Prosthetic
joint infection (PJI) is a devastating complication
requiring surgical intervention and prolonged antimicrobial treatment.
The prevalence of PJI is on the rise, with an average incidence of
60,000 cases per year and a projected annual cost of $1.85 billion
in the US. The underlying pathogenesis of PJI involves the formation
of bacterial biofilms that protect the pathogen from the host immune
response and antibiotics, making it difficult to eradicate such infections.
Biofilms on implants are also resistant to mechanical brushing/scrubbing
methods of removal. Since the removal of biofilms is currently only
achievable by the replacement of the prosthesis, therapies aimed at
eradicating biofilms while enabling retention of implants will revolutionize
the management of PJIs. To address severe complications associated
with biofilm-related infections on implants, we have developed a combination
treatment that is based on a hydrogel nanocomposite system, containing d-amino acids (d-AAs) and gold nanorods, which can
be delivered and transforms from a solution to a gel state at physiological
temperature for sustained release of d-AAs and light-activated
thermal treatment of infected sites. Using this two-step approach
to utilize a near-infrared light-activated hydrogel nanocomposite
system for thermal treatment, following initial disruption with d-AAs, we were able to successfully demonstrate in vitro the total eradication of mature Staphylococcus aureus biofilms grown on three-dimensional printed Ti-6Al-4V alloy implants.
Using a combination of cell assays, computer-aided scanning electron
microscopy analyses, and confocal microscopy imaging of the biofilm
matrix, we could show 100% eradication of the biofilms using our combination
treatment. In contrast, we were only able to see 25% eradication of
the biofilms using the debridement, antibiotics, and implant retention
method. Moreover, our hydrogel nanocomposite-based treatment approach
is adaptable in the clinical setting and capable of combating chronic
infections brought about by biofilms on medical implants.